DCM
ALDR
DAFNA Capital Management’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-636,013
| Closed | -$12M | – | 96 |
|
|
2019
Q3 | $12M | Hold |
636,013
| – | – | 4.51% | 3 |
|
|
2019
Q2 | $7.49M | Buy |
636,013
+65,000
| +11% | +$765K | 2.81% | 5 |
|
|
2019
Q1 | $7.79M | Buy |
571,013
+175,000
| +44% | +$2.39M | 3.36% | 5 |
|
|
2018
Q4 | $4.06M | Hold |
396,013
| – | – | 2.02% | 14 |
|
|
2018
Q3 | $6.59M | Hold |
396,013
| – | – | 2.71% | 9 |
|
|
2018
Q2 | $6.26M | Hold |
396,013
| – | – | 2.93% | 7 |
|
|
2018
Q1 | $5.03M | Buy |
396,013
+50,000
| +14% | +$635K | 2.45% | 11 |
|
|
2017
Q4 | $3.96M | Hold |
346,013
| – | – | 2.13% | 16 |
|
|
2017
Q3 | $4.24M | Buy |
346,013
+125,000
| +57% | +$1.53M | 2.63% | 9 |
|
|
2017
Q2 | $2.53M | Hold |
221,013
| – | – | 1.81% | 13 |
|
|
2017
Q1 | $4.6M | Hold |
221,013
| – | – | 3.89% | 4 |
|
|
2016
Q4 | $4.6M | Buy |
221,013
+55,700
| +34% | +$1.16M | 4.04% | 3 |
|
|
2016
Q3 | $5.42M | Hold |
165,313
| – | – | 3.77% | 6 |
|
|
2016
Q2 | $4.13M | Buy |
165,313
+25,000
| +18% | +$624K | 3.27% | 6 |
|
|
2016
Q1 | $3.44M | Buy |
140,313
+122,313
| +680% | +$3M | 2.96% | 8 |
|
|
2015
Q4 | $595K | Hold |
18,000
| – | – | 0.53% | 48 |
|
|
2015
Q3 | $590K | Buy |
+18,000
| New | +$590K | 0.59% | 44 |
|